Myriad Genetics, Inc. MYGN was a big mover last session, as its shares rose over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for …
12/16 Myriad Genetics $MYGN Sees Large Volume Increase 12/15 $MYGN New SEC Document(s) for Myriad …
A new research note from Cantor Fitzgerald profiles stocks with upcoming earnings ... The company reports earnings on November 6. Myriad Genetics Inc. (NASDAQ: MYGN) is a biotech stock that has hammered the shorts so far this year, …
For a hedged play on Myriad Genetics (MYGN), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Feb 16, 2018 $33 covered call for a net debit in the $31.80 area. That is also the break-even stock price …
... Having more Current Assets provides flexibility for MYGN. This also supports the short squeeze possibility. If you read my post on Accenture and how share buybacks create a floor to the stock price, MYGN has also been buying back …
The stock has gained 21.32% over the last year. 7. Maxim Integrated Products Inc. (MXIM): Semiconductor Line Industry. Market cap of $6.44B. Current price at $21.86. MYGN recently set aside $200 million for share buybacks. Might be …
Myriad Genetics, Inc. (NASDAQ: MYGN) today announced that the NYSE's Listing and Compliance ... the NYSE Big Board in the second calendar quarter of 2009. Upon transfer the stock will trade under the new ticker symbol "MGX." …
MYGN maintains a pristine balance sheet with no debt and the ... driving market share and increasing growth in the company's stock price. Bevec wrote, "Given the breadth of the company's portfolio, TMO is essentially a one-stop shop …
Myriad Genetics Inc. (MYGN) reported second quarter adjusted EPS of $0.40 after ... Myriad Genetics traded in a range for the bulk of Tuesday's session and closed up by 0.73 at $38.12. The stock is now down 6.34 on 122K shares after the bell.
Myriad Genetics, Inc. MYGN presented encouraging data from a study to evaluate ... Over the past year, the company’s share price has outperformed the broader industry. The stock has gained 90.1%, in contrast to the broader industry’s …